Kestra Medical Technologies (KMTS) Stock Forecast: StockMap's 2-Week Call

KMTS stock forecast: StockMap's model leans Underperform on Kestra Medical Technologies for the two weeks after the Nov 19 close, toward KMTS trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 3 of 6 two-week windows on KMTS since Aug 21; by chance, a call on the same dates was right 58% of the time.

Kestra Medical Technologies last closed at $26.63, -5.87% on the session.

Against the IVW growth benchmark the position is -3.54% over the forecast window.

Kestra Medical Technologies' market cap is $1.59B as of November 19, 2026.

Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -33 (too close to call).

Where KMTS sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

44 daily calls for KMTS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Kestra Medical Technologies in the 15th percentile on return on equity, where 100 is best.

Kestra Medical Technologies is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks Kestra Medical Technologies as the 47th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.

On that composite Kestra Medical Technologies ranks 102nd of 141 in the group, against a group median of -0.18.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Kestra Medical Technologies (KMTS) — StockMap 2-week forecast & tracked accuracy